Form 4: Medtronic EVP Michael Marinaro Executes Stock Options and Disposes of Shares

Medtronic's EVP & President, Surgical OU, Michael Marinaro, exercised stock options and disposed of shares to cover tax obligations.

Summary

• On January 27, 2025, Michael Marinaro, EVP & President, Surgical OU of Medtronic plc, exercised stock options to acquire 2,345 ordinary shares at a price of $74.84.
• Simultaneously, Marinaro disposed of 2,073 ordinary shares at $92.46 to satisfy tax obligations related to the option exercise.
• Following these transactions, Marinaro directly owns 41,250 ordinary shares.
• He also holds options for an additional 0 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects routine transactions related to executive compensation and tax obligations.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. These transactions are closely watched by investors for insights into management's view of the company's prospects, although option exercises and sales for tax purposes are generally not considered indicative of a change in sentiment.

Comparison to Industry Standards

• Executive compensation packages often include stock options, aligning management's interests with shareholders.
• The exercise and sale of shares to cover taxes are standard practice among executives at Medtronic and similar companies like Johnson & Johnson and Abbott Laboratories.
• The reported transactions are typical in terms of volume and price compared to other insider filings in the medical device industry.

Key Dates